Prognostic Model of Hypertension (PHOP-HT)

Xinjiang Medical University

Status: Enrolling

Conditions: Hypertension

Treatments: Other: Standard therapy

Study type: Observational

Funder types: Other

Identifiers

NCT06160921

20190818

Details and patient eligibility

About

The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.

Full description

The aim of the study is to establish a platform for monitoring, clinical research and translational medicine in Xinjiang, which aims to provide a basis for future quality improvement and research, and to promote efforts to improve the prognosis of patients with hypertension, and to translate research into improved care for patients, thereby reducing Morbidity and mortality associated with hypertension.

Enrollment: 50,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University

Exclusion criteria

• Patients with secondary hypertension, patients with liver and kidney dysfunction,
• patients with mental disorders, and patients who are unwilling to participate in this trial

Trial design

50,000 participants in 1 patient group

2

Treatment:

Other: Standard therapy